Sequelae of poliomyelitis

AB1_SEQULAE_POLIO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B91 Hospital discharge: ICD-9 — 138 Hospital discharge: ICD-8 — 04[4] Cause of death: ICD-10 — B91 Cause of death: ICD-9 — 138 Cause of death: ICD-8 — 04[4] 2 out of 7 registries used, show all original rules.	301
4. Check minimum number of events None	301
5. Include endpoints None	301
6. Filter based on genotype QC (FinnGen only)	272

Control definitions (FinnGen only)

Control exclude: AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_SEQULAE_POLIO
CONTROL_EXCLUDE	AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B91
HD_ICD_9	138
HD_ICD_8	04[4]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B91
COD_ICD_9	138
COD_ICD_8	04[4]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sequelae of poliomyelitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3267	1689	1520
Only index persons	2365	1316	1049
Unadjusted period prevalence (%)
Whole population	0.05	0.05	0.04
Only index persons	0.04	0.05	0.04
Median age at first event (years)
Whole population	58.93	58.69	59.11
Only index persons	57.84	57.31	58.50

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	272	128	144
Unadjusted period prevalence (%)	0.06	0.05	0.07
Median age at first event (years)	59.70	57.98	61.23

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
287: Matched controls
2870

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B91

ICD-10 Finland

Sequelae of poliomyelitis

4503599627370496.0

307.7

251

1380A

ICD-9 Finland

Late effects of acute poliomyelitis[SEQUELAE POLIOMYELITIDIS]

+∞

80.0

N70

ICPC

Poliomyelitis

+∞

60.6

04499

ICD-8 Finland

Late effects of actue poliomyelitis

+∞

57.2

L28

ICPC

Limited function/disability (L)

3.8

26.8

124

476

SPAT1229

SPAT

Assessment of need for aid

4.5

19.9

148

N18

ICPC

Paralysis/weakness

7.4

16.0

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

6.7

15.8

A28

ICPC

Limited function/disability NOS

2.7

13.4

106

519

M89.6

ICD-10 Finland

Osteopathy after poliomyelitis

+∞

11.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

10.4

339

Z02.7

ICD-10 Finland

Issue of medical certificate

3.5

9.2

107

S72.4

ICD-10 Finland

Fracture of lower end of femur

15.1

8.3

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

8.1

218

R5110, ,

SPAT

2.7

7.9

195

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

7.8

331

XG466

NOMESCO Finland

Sleep oxymetry

4.7

7.8

N03AX16

ATC

[U] pregabalin

2.2

7.3

436

M41.9

ICD-10 Finland

Scoliosis, unspecified

9.7

6.9

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.9

6.8

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.1

6.6

N03AE01

ATC

clonazepam; systemic

3.3

6.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

549

1.72

3.97

3.8

4.2

78.14

260.34

ng/l

1.52

481

(3024561) Albumin [Mass/volume] in Serum or Plasma

154

1202

1.61

3.81

6.0

4.8

33.73

34.83

g/l

1.51

143

1120

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

248

1.91

3.54

1.6

2.2

0.22

0.21

g/l

0.22

227

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

323

1.74

3.06

5.5

4.3

19.08

41.48

ug/l

0.37

278

(3003396) Base excess in Arterial blood by calculation

365

1.70

3.01

6.1

7.0

1.98

0.93

mmol/l

1.34

303

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

141

1126

1.50

2.86

2.8

2.4

80.48

79.70

nmol/l

0.12

127

987

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

168

1392

1.50

2.83

9.3

7.1

1.22

1.21

mmol/l

0.54

148

1201

(3019977) pH of Arterial blood

374

1.65

2.75

6.3

6.9

7.42

0.18

227

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

6.10

2.71

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

171

1.91

2.67

4.8

7.3

25.99

24.56

mmol/l

1.26

171

(3000991) Gas panel - Venous blood

250

1.75

2.58

6.9

8.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

152

1250

1.46

2.56

7.4

6.5

1.21

mmol/l

0.01

141

1141

(36660697) Celiac disease serology panel - Serum

159

1.92

2.55

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

502

1.55

2.51

2.1

2.0

—

(3023368) Bacteria identified in Blood by Culture

107

827

1.47

2.47

4.2

4.4

—

(3044290) Cell count panel - Cerebral spinal fluid

2.68

2.39

1.2

1.1

—

(42870588) Differential panel, method unspecified - Blood

104

809

1.45

2.29

5.6

5.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

162

1369

1.42

2.24

7.9

6.9

11.38

12.09

umol/l

0.44

153

1301

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

245

1.68

2.22

3.5

2.3

34.09

33.19

u/l

0.06

202

(40758558) Short blood count panel - Blood

741

1.44

2.19

7.8

6.4

—

(3018418) pH of Serum or Plasma

109

862

1.43

2.18

5.1

4.4

7.39

7.40

0.40

630

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

600

1.46

2.11

4.4

3.1

2.48

2.46

mmol/l

0.86

537

(40760892) CBC W Ordered Manual Differential panel - Blood

465

0.58

2.06

5.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

3.13

2.03

1.8

1.5

17.31

35.32

ng/l

—

(3000492) Spirometry study

187

0.41

2.01

1.6

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

157

1.79

2.01

2.6

2.9

2.52

1.97

mmol/l

0.45

118

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

369

1.54

1.99

2.2

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

2.06

1.94

2.9

3.9

3.86

1.59

index

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

183

1.71

1.91

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

114

933

1.37

1.80

4.6

3.3

2.35

mmol/l

0.04

104

835

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

353

1.50

1.77

2.2

2.0

—

(3011648) Oxygen content in Venous blood

2.96

1.73

1.0

1.7

8.94

10.98

—

(3021960) Folate [Moles/volume] in Serum or Plasma

104

844

1.36

1.71

1.8

19.58

20.98

nmol/l

0.48

687

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

1.70

0.0

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.23

1.70

1.2

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

464

1.43

1.64

4.2

3.4

3.24

1.89

e6/l

0.31

243

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

144

1235

1.33

1.63

2.5

2.2

90.69

94.00

pmol/l

0.35

643

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

151

1709

0.75

1.57

4.1

4.2

15.59

15.16

pmol/l

1.21

140

1508

(3037467) Urinalysis macro (dipstick) panel - Urine

187

1685

1.32

1.40

5.4

5.2

—

2.34

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

204

1863

1.33

1.37

9.6

8.7

85.50

80.24

u/l

0.55

195

1757

(3025130) Human papilloma virus identified in Specimen

2.97

1.36

1.6

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

1.35

0.0

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

1.35

0.0

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

230

0.54

1.34

3.4

4.7

1.57

0.86

—

(3019060) Gas panel - Arterial blood

194

1.55

1.33

4.6

4.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

723

1.31

1.29

2.7

2.2

2.75

3.05

mg/l

0.61

628

(3021440) Promyelocytes/Leukocytes in Blood

215

0.54

1.29

3.3

4.8

0.00

0.13

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.81

1.29

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.26

1.25

1.0

1.4

—

(3026008) Bacteria identified in Urine by Culture

107

907

1.29

1.24

4.1

3.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

206

1.51

1.23

2.1

1.6

—

(3018095) Leukocytes [#/volume] in Urine

115

985

1.28

1.23

5.4

4.5

761.75

125.99

e6/l

0.52

731

(3002032) Base excess in Venous blood by calculation

292

1.43

1.22

3.9

3.4

2.62

1.95

mmol/l

0.67

245

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

767

1.29

1.21

3.5

38.10

33.64

u/l

0.47

723

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

489

1.34

1.20

4.1

3.2

0.69

1.03

e6/l

0.56

266

(3025159) Blasts/Leukocytes in Blood

222

0.57

1.20

3.7

5.1

0.00

0.22

—

(3032080) INR in Blood by Coagulation assay

152

1350

1.27

1.20

11.6

16.7

1.28

1.32

inr

0.42

126

1122

(3007853) Bacteria identified in Skin by Aerobe culture

285

1.43

1.19

2.2

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

1.16

0.0

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.53

1.15

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

210

1.48

1.14

4.4

3.3

115.78

84.79

ng/l

0.66

179

(3012544) pH of Venous blood

307

1.39

1.10

3.8

3.4

7.36

7.38

1.60

183

(3042936) Bacteria identified in Isolate by Culture

396

1.35

1.10

2.2

2.0

—

(3002179) Metamyelocytes/Leukocytes in Blood

216

0.58

1.09

3.7

4.6

0.86

0.51

—

(36304419) Bacteria [Presence] in Urine

730

1.28

1.08

4.2

3.5

—

0.00

estimate

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

479

1.32

1.08

1.4

1.3

15.99

0.96

u/ml

—

127

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

344

0.67

1.08

1.1

1.4

1.28

19.18

u/ml

—

119

(3002256) Pathology report gross observation

309

1.38

1.06

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.15

1.06

1.0

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.87

1.04

1.3

1.9

—

(3002030) Lymphocytes/Leukocytes in Blood

127

1118

1.24

1.04

6.2

25.01

25.73

0.30

121

1051

(3022313) Gas panel - Capillary blood

131

1.57

1.03

3.2

2.9

—

(1616796) Gas panel - Central venous blood

1.92

1.02

2.9

3.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

538

1.29

1.02

2.0

1.7

1146.76

1165.22

nmol/l

0.06

409

(3021788) Differential panel - Synovial fluid

1.90

1.01

1.4

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

304

0.67

0.99

8.8

7.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.97

0.97

1.0

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1.68

0.96

2.0

2.2

0.28

0.33

iu/ml

—

(3006504) Eosinophils/Leukocytes in Blood

125

1106

1.23

0.96

6.3

6.1

2.97

2.77

0.38

119

1027

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.95

0.0

1.7

—

(3019069) Monocytes/Leukocytes in Blood

125

1107

1.23

0.95

6.5

6.3

8.54

9.02

1.17

118

1031

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.85

0.93

1.0

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.85

0.93

1.0

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

105

915

1.23

0.92

4.7

3.7

61.14

128.89

e6/l

0.41

713

(1761868) Lipid panel - Serum or Plasma

640

0.77

0.92

3.5

3.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.17

0.92

1.2

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

436

1.29

0.90

1.5

2.84

2.68

g/l

0.19

239

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

2.09

0.90

1.5

2.7

20.83

72.89

u/ml

—

(3022096) Basophils/Leukocytes in Blood

124

1104

1.22

0.88

6.5

6.2

0.65

0.64

0.10

118

1026

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.02

0.87

1.7

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

191

2036

0.81

0.86

4.1

4.6

1.27

1.24

mmol/l

0.28

172

1810

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

339

0.71

0.85

5.5

5.2

28.29

32.32

1.58

204

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.95

0.85

1.2

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

788

1.23

0.84

2.8

2.5

55.24

69.27

u/l

0.98

732

(3044927) Protein electrophoresis panel - Urine

1.89

0.82

1.3

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.84

0.79

1.2

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.84

0.79

1.2

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.84

0.79

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.61

0.79

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.54

0.77

1.3

—

(3018010) Neutrophils/Leukocytes in Blood

123

1106

1.20

0.77

6.2

6.1

59.59

58.78

0.30

117

1046

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.78

0.76

1.0

1.4

1.08

0.61

nmol/l

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

116

1.49

0.76

2.5

2.0

902.66

339.42

ug/l

0.50

110

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.63

0.73

1.9

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

2.02

0.73

1.6

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

1.60

0.72

1.4

1.2

—

45.00

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.94

0.71

1.6

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.72

0.70

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

1.68

0.69

1.4

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.87

0.68

1.0

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

197

2076

0.84

0.68

5.3

1.76

2.03

mu/l

2.31

179

1846

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

209

2190

0.83

0.67

5.6

5.8

6.20

6.13

mmol/l

0.26

190

1966

(4146454) Self-monitoring of blood glucose

1.80

0.66

2.4

2.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.61

0.65

1.3

1.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

199

1.34

0.65

1.3

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

280

1.28

0.65

3.5

3.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.48

0.62

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

1.62

0.62

3.0

4.7

8.89

7.89

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1.62

0.62

3.0

4.7

5.30

5.06

kpa

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.68

0.61

2.0

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1.68

0.61

3.2

3.0

2.66

9.13

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.68

0.61

1.0

1.4

0.26

0.20

nmol/l

—

(3035715) Granulocytes [#/volume] in Blood

1.68

0.61

3.0

2.4

3.80

5.34

e9/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.60

0.0

4.4

—

0.95

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.60

0.0

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.58

0.0

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

109

990

1.16

0.58

4.6

3.6

—

(3035350) Ketones [Presence] in Urine by Test strip

139

1286

1.16

0.58

3.9

4.6

0.00

5.43

estimate

0.50

299

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

141

1306

1.16

0.58

3.5

54.95

55.75

u/l

0.04

128

1205

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1.45

0.57

3.1

3.4

25.45

25.35

mmol/l

0.06

(3023420) DNA double strand Ab [Units/volume] in Serum

0.56

0.57

1.2

1.6

—

10.54

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.55

0.57

1.0

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

230

2213

1.20

0.56

24.3

19.7

29.64

26.66

mg/l

0.73

202

1884

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

203

2121

0.85

0.56

5.0

5.5

1.45

1.47

mmol/l

0.20

185

1898

(3049717) Cytology report of Urine Cyto stain

134

1.37

0.54

3.4

2.9

—

(40768800) Prostate Pathology biopsy report

1.49

0.54

1.0

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.45

0.54

3.8

4.9

2.01

3.61

ratio

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.53

0.53

2.3

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

841

1.16

0.52

2.5

2.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

137

1274

1.14

0.51

3.9

4.5

0.00

estimate

-0.00

290

(3017446) Testosterone [Moles/volume] in Serum or Plasma

171

1.31

0.51

1.9

2.2

14.69

13.47

nmol/l

0.36

150

(3013826) Glucose [Moles/volume] in Serum or Plasma

163

1534

1.14

0.51

6.3

5.2

6.96

6.86

mmol/l

0.21

155

1468

(3022621) pH of Urine by Test strip

208

1.27

0.50

3.2

3.1

5.92

6.06

0.38

154

(3026493) Urate [Moles/volume] in Serum or Plasma

659

0.85

0.49

2.8

3.2

339.71

355.75

umol/l

0.53

557

(3030467) Casts [#/volume] in Urine by Automated count

796

1.15

0.49

4.3

3.6

0.33

0.51

e6/l

0.53

596

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1.50

0.48

3.1

2.9

16.00

32.31

u/ml

—

(3005322) IgE [Units/volume] in Serum or Plasma

119

0.66

0.46

1.1

1.2

65.27

366.84

u/ml

—

109

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

212

2197

0.87

0.46

6.0

6.5

2.51

mmol/l

0.01

192

1971

(3013650) Neutrophils [#/volume] in Blood by Automated count

144

1351

1.13

0.46

10.0

9.9

4.49

4.25

e9/l

0.37

117

1173

(3001122) Ferritin [Mass/volume] in Serum or Plasma

111

1026

1.13

0.45

3.3

2.9

129.12

139.53

ug/l

0.22

105

932

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

206

2137

0.87

0.45

5.1

5.6

4.38

4.42

mmol/l

0.24

189

1925

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.39

0.44

1.2

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

124

1156

1.13

0.43

2.7

3.0

—

estimate

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.62

0.43

1.8

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1.62

0.43

2.6

4.3

425.20

347.58

umol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1.41

0.42

6.5

4.5

99.50

552.77

u/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.57

0.42

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1.57

0.42

1.2

1.1

152.00

388.50

u/ml

—

(21494434) Karyotype in Bone marrow

1.52

0.41

1.2

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

138

1298

1.12

0.41

3.9

4.6

0.00

1.10

estimate

0.50

272

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

110

1021

1.13

0.41

2.8

2.3

—

(3024263) Appearance of Synovial fluid

0.00

0.41

0.0

1.3

—

(3020491) Glucose [Moles/volume] in Blood

0.00

0.41

0.0

2.6

—

7.21

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

0.41

0.0

4.0

—

19.68

—

(3019225) pH of Specimen

261

1.21

0.40

6.5

4.0

7.39

7.34

2.35

181

(3029937) Albumin [Presence] in Urine by Test strip

741

0.88

0.40

4.9

4.5

0.00

0.01

estimate

0.50

259

(4195642) Thrombophilia screening test

0.00

0.40

0.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.40

0.0

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

0.00

0.40

0.0

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1.42

0.39

3.6

3.1

0.84

0.88

nmol/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

159

0.74

0.39

1.3

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.44

0.39

2.4

4.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

375

0.83

0.39

1.3

13.70

44.11

iu/ml

—

130

(3015736) pH of Urine

108

1004

1.12

0.39

3.2

4.0

6.19

6.27

0.28

552

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.39

0.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.39

0.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.39

0.0

1.2

—

(40768804) Tissue Pathology biopsy report

101

936

1.12

0.39

2.1

2.3

—

(3037121) Protein [Mass/volume] in Urine

1.36

0.38

5.7

3.2

160.00

199.03

mg/l

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

208

2148

0.88

0.38

7.2

7.4

40.06

40.52

mmol/mol

0.30

188

1981

(3025941) Bacteria identified in Stool by Culture

115

0.69

0.37

1.1

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.37

0.36

1.2

1.4

—

(3019150) Specific gravity of Urine by Refractometry

559

1.14

0.36

4.3

4.9

1.02

kg/l

0.04

390

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.64

0.36

1.0

1.6

—

(3013115) Eosinophils [#/volume] in Blood

131

1237

1.11

0.35

6.4

6.2

0.19

e9/l

0.00

106

1063

(3001604) Monocytes [#/volume] in Blood

127

1198

1.11

0.35

6.1

6.0

0.59

0.60

e9/l

0.27

101

1020

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

958

0.90

0.34

5.4

5.9

4.92

2.93

ug/l

0.30

847

(3012516) Albumin [Mass/volume] in Urine

917

0.90

0.34

4.4

3.4

95.76

53.80

mg/l

0.46

604

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

640

1.12

0.33

2.6

2.5

—

(4034850) Laboratory test

0.66

0.33

10.8

10.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

209

2151

0.90

0.33

25.7

19.7

81.92

72.49

ml/min/173m2

7.35

187

2018

(3035933) Granulocytes/Leukocytes in Blood

1.28

0.32

2.8

2.6

58.83

60.40

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

104

1107

0.91

0.32

3.8

4.5

80.25

45.05

ng/l

0.63

905

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.30

0.30

1.6

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

596

1.12

0.30

3.9

4.2

—

0.25

—

(3006315) Basophils [#/volume] in Blood

127

1207

1.09

0.29

6.1

6.0

0.04

e9/l

0.10

101

1029

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.30

0.28

2.0

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

560

0.89

0.28

2.7

3.4

0.93

0.83

ug/l

0.41

408

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.29

0.26

1.5

—

11.04

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.70

0.26

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.69

0.26

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.69

0.26

1.0

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.22

0.25

1.4

1.2

—

3.83

—

(3020682) Albumin/Creatinine [Ratio] in Urine

944

0.92

0.25

5.2

4.0

19.78

9.39

mg/mmol

0.52

591

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

137

0.80

0.25

2.2

2.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

918

1.09

0.24

2.0

1.24

1.26

mmol/l

0.11

738

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

200

0.84

0.23

1.4

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1.32

0.23

1.8

1.1

4.18

9.35

u/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

577

1.10

0.22

1.9

1.8

459.90

434.20

pmol/l

0.27

480

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.22

0.22

1.4

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

999

0.93

0.22

2.6

3.3

1264.29

1762.14

ng/l

0.66

869

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1.19

0.21

2.6

5.3

8.64

11.91

mg/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.21

0.0

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(4211845) Urine protein measurement

0.00

0.21

0.0

5.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

34.10

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.1

—

8.40

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

189.00

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.21

0.0

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1.17

0.21

1.8

2.5

35.20

32.72

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

240

1.14

0.21

4.0

2.6

0.28

0.89

e6/l

0.83

227

(3019198) Lymphocytes [#/volume] in Blood

127

1221

1.07

0.21

6.1

1.63

1.88

e9/l

1.59

105

1074

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.21

0.0

6.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.21

0.0

1.3

—

0.79

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

3.1

—

6.22

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

112

0.80

0.20

1.2

2.8

4.46

4.25

pmol/l

—

100

(40768443) Skin Pathology biopsy report

113

0.79

0.20

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.20

0.0

1.1

—

(3028433) Virus identified in Specimen by Culture

0.00

0.20

0.0

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

1.59

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.20

0.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.23

0.20

1.7

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.20

0.20

1.0

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

185

1.15

0.18

1.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

769

0.93

0.17

3.7

4.9

23.62

22.05

0.38

419

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

179

1748

1.06

0.17

4.6

4.8

16.70

14.18

mm/h

1.30

174

1601

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.71

0.17

1.0

1.2

—

(3003694) ABO and Rh group [Type] in Blood

605

1.07

0.16

1.2

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

287

0.90

0.16

1.3

240.00

565.80

titre

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

214

0.88

0.16

3.1

4.4

1.24

1.22

mmol/l

1.42

188

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.13

0.16

1.1

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

216

1.12

0.16

1.3

—

(3037756) Immunofixation for Serum or Plasma

1.10

0.16

4.0

1.7

—

(3010421) pH of Blood

1.11

0.15

2.9

4.1

7.41

—

(3000494) Fungus identified in Specimen by Culture

305

0.91

0.14

1.8

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

139

0.86

0.14

1.8

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

103

1.17

0.14

2.5

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

0.82

0.14

1.0

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.81

0.14

2.6

2.4

0.00

g/l

—

(3048689) Calprotectin [Mass/mass] in Stool

258

1.09

0.13

2.3

2.1

227.37

147.15

ug/g

0.43

211

(3026782) Osmolality of Urine

572

1.06

0.12

2.9

3.4

528.37

537.84

mosm/kgh2o

0.16

503

(3004119) Hemoglobin [Mass/volume] in Venous blood

188

0.90

0.11

1.4

2.9

138.06

127.81

g/l

1.05

183

(3021589) Normoblasts [#/volume] in Blood

108

1051

1.04

0.11

11.7

12.9

0.00

e9/l

0.64

870

(3036481) Cortisol [Moles/volume] in Serum or Plasma

251

1.08

0.10

3.0

2.1

377.11

377.71

nmol/l

0.01

236

(3004588) Protein electrophoresis panel - Serum or Plasma

212

1.09

0.10

4.8

3.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.09

0.09

2.6

2.9

9.10

9.75

pmol/l

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.06

0.09

1.0

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1.06

0.09

1.0

1.4

—

132.00

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

223

1.08

0.09

1.5

1.4

—

(3022145) Colonoscopy Study observation

288

0.93

0.09

1.8

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

964

0.96

0.08

4.2

4.6

0.00

0.03

estimate

1.23

244

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

113

0.88

0.08

1.9

3.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.79

0.08

1.2

—

2.32

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.78

0.08

1.2

1.3

—

2.62

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.03

0.08

1.7

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

294

1.06

0.07

2.9

3.0

73.48

68.37

e9/l

0.18

225

(3027945) Reticulocytes/Erythrocytes in Blood

383

1.05

0.07

2.5

2.9

1.67

1.78

0.30

344

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.86

0.07

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

122

0.90

0.07

1.8

1.3

—

60.15

—

(3041096) Erythrocytes [Presence] in Urine by Automated

681

1.04

0.07

3.5

4.2

0.00

0.12

estimate

0.55

229

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.89

0.07

2.6

2.4

0.00

g/l

—

(3007461) Platelets [#/volume] in Blood

237

2354

1.04

0.06

33.4

29.6

255.12

240.10

e9/l

2.52

227

2305

(3026361) Erythrocytes [#/volume] in Blood

237

2354

1.04

0.06

33.8

29.6

4.30

4.39

e12/l

1.65

227

2291

(3010813) Leukocytes [#/volume] in Blood

237

2354

1.04

0.06

33.8

29.6

7.15

6.96

e9/l

0.52

228

2292

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

862

1.03

0.06

2.7

2.2

499.19

226.24

u/l

0.45

814

(40761511) CBC panel - Blood by Automated count

225

2236

1.03

0.04

18.7

17.7

—

(40768797) Stomach Pathology biopsy report

338

1.04

0.04

1.3

1.2

—

(3044889) 12 lead EKG panel

167

1655

1.02

0.04

4.4

4.8

—

0.20

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

229

2303

0.97

0.04

14.4

13.5

26.75

23.85

u/l

1.27

221

2219

(3013139) Helicobacter pylori Ag [Presence] in Stool

141

1.07

0.03

1.1

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

108

0.92

0.03

4.1

2.5

1.72

1.06

g/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

231

1.04

0.03

1.7

1.4

—

(4024509) Urine culture

122

1.07

0.02

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

113

1.06

0.02

2.7

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

166

0.96

0.00

1.6

2.4

0.56

0.63

0.30

166

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

548

1.00

0.00

1.5

1.7

1.20

1.62

mg/l

0.86

442

(40761536) Microorganisms panel - Urine sediment

189

1.01

0.00

4.9

4.2

—

(3009508) Creatinine [Moles/volume] in Urine

921

1.00

0.00

4.2

3.3

6.40

7.22

mmol/l

1.43

763

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1.03

0.00

2.3

0.00

g/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

223

0.99

0.00

1.4

—

(4035726) Immunohistochemistry procedure

234

0.98

0.00

1.7

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

0.0

3.8

—

52.83

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

0.0

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

0.0

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.0

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.0

2.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.5

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

0.0

1.5

—

7.00

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

0.00

-0.00

0.0

1.0

—

20.80

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

1.1

—

0.00

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.2

—

93.80

—

(40757373) Influenza virus identified in Isolate

0.00

-0.00

0.0

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.8

—

109.11

—

(4015189) Microbial culture of sputum

0.00

-0.00

0.0

3.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.6

—

0.69

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

170

1.00

-0.00

1.5

2.5

1.34

1.11

0.64

170

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.7

—

23.11

—

(3006462) Nitrate [Presence] in Urine

0.00

-0.00

0.0

6.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

1.8

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

-0.00

0.0

1.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

157.14

—

(3014891) Appearance of Pleural fluid

0.00

-0.00

0.0

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1399.43

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.7

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3000012) Reticulocyte production index

0.98

-0.00

3.2

2.6

0.54

0.89

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

-0.00

0.0

3.6

—

6.24

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.2

—

110.20

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.2

—

89.40

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

1055.29

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.2

—

1.06

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.0

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

200

1.00

-0.00

4.3

3.2

73.55

57.20

ml/min/173m2

0.75

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_SEQULAE_POLIO and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_SEQULAE_POLIO	1.391 [1.15, 1.68]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.261

During the follow-up period (1.1.1998 — 31.12.2019), 218 out of 652 females with AB1_SEQULAE_POLIO died.

Males

Parameter	HR [95% CI]	p-value
AB1_SEQULAE_POLIO	1.694 [1.4, 2.05]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 273 out of 623 males with AB1_SEQULAE_POLIO died.

Mortality risk

Mortality risk for people of age

years, who have AB1_SEQULAE_POLIO.

N-year risk	Females	Males
1	0.116%	0.295%
5	0.895%	1.986%
10	2.244%	4.869%
15	4.346%	9.197%
20	7.669%	15.654%

Relationships between endpoints

↥

Index endpoint: AB1_SEQULAE_POLIO – Sequelae of poliomyelitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sequelae of poliomyelitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints